P-319Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer. (2nd July 2019) - Fornaro, L; Vivaldi, C; Orlandi, P; Musettini, G; Pecora, I; Gentile, D; Catanese, S; Lencioni, M; Salani, F; Pasquini, G; Massa, V; Di Desidero, T; et al.